chrX-53210820-G-A
Variant summary
Our verdict is Pathogenic. Variant got 15 ACMG points: 15P and 0B. PM2PP2PP3_StrongPP5_Very_Strong
The NM_004187.5(KDM5C):c.1439C>T(p.Pro480Leu) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.000000911 in 1,097,861 control chromosomes in the GnomAD database, with no homozygous occurrence. There are no hemizygote samples in GnomAD. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★).
Frequency
Consequence
NM_004187.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 15 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
KDM5C | NM_004187.5 | c.1439C>T | p.Pro480Leu | missense_variant | 11/26 | ENST00000375401.8 | NP_004178.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
KDM5C | ENST00000375401.8 | c.1439C>T | p.Pro480Leu | missense_variant | 11/26 | 1 | NM_004187.5 | ENSP00000364550 | P5 |
Frequencies
GnomAD3 genomes Cov.: 23
GnomAD4 exome AF: 9.11e-7 AC: 1AN: 1097861Hom.: 0 Cov.: 31 AF XY: 0.00 AC XY: 0AN XY: 363223
GnomAD4 genome Cov.: 23
ClinVar
Submissions by phenotype
Syndromic X-linked intellectual disability Claes-Jensen type Pathogenic:3
Pathogenic, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | May 05, 2022 | Variant summary: KDM5C c.1439C>T (p.Pro480Leu) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant was absent in 183427 control chromosomes. c.1439C>T has been reported in the literature in individuals affected with Mental Retardation, Syndromic, Claes-Jensen Type, X-Linked. These data indicate that the variant is likely to be associated with disease. At least one publication reports experimental evidence evaluating an impact on protein function and showed that p.P480L leads to reduced stability and enzymatic activity (Brookes_2015). Two clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 without evidence for independent evaluation. Both laboratories classified the variant as pathogenic. Based on the evidence outlined above, the variant was classified as pathogenic. - |
Pathogenic, criteria provided, single submitter | clinical testing | Department of Genetics, Rouen University Hospital, Normandy Center for Genomic and Personalized Medicine | May 10, 2022 | - - |
Likely pathogenic, no assertion criteria provided | clinical testing | Baylor Genetics | Jun 19, 2014 | A likely pathogenic variant in KDM5C was reported in this individual, who has delayed motor milestones, delayed speech, intellectual disability, hypotonia, dysmorphic features (prominent chin, mild plagiocephaly), short stature, microcephaly, strabismus, and an ectopic posterior pituitary. This change has been recently in two brothers affected with X-linked intellectual disability [PMID: 23356856]. A pathogenic variant in GLI2 (NM_005270.4; c.891delG) was also reported in this individual by our laboratory. - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | GeneDx | Oct 22, 2021 | Published functional studies demonstrate a damaging effect, including reduced protein stability and demethylase activity (Brookes et al., 2015); Not observed in large population cohorts (gnomAD); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; This variant is associated with the following publications: (PMID: 23356856, 27959697, 25666757, 29456765, 25666439) - |
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Dec 01, 2023 | KDM5C: PS2, PM2, PS4:Moderate, PP2, PP3, PS3:Supporting - |
Spastic paraplegia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 07, 2018 | For these reasons, this variant has been classified as Pathogenic. Experimental studies have shown that this missense disrupts KDM5C protein function (PMID: 25666439). This variant has been observed to be de novo in both males and females affected with syndromic intellectual disability (PMID: 25666757, 27959697). It has also been observed to segregate with disease in related individuals (PMID: 23356856). ClinVar contains an entry for this variant (Variation ID: 374324). This variant is not present in population databases (ExAC no frequency). This sequence change replaces proline with leucine at codon 480 of the KDM5C protein (p.Pro480Leu). The proline residue is highly conserved and there is a moderate physicochemical difference between proline and leucine. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at